Global Nutrigenomics Market

Nutrigenomics Comprehensive Study by Type (Reagents & kits, Services), Application (Obesity, Diabetes, Anti-Aging, Chronic Diseases), Techniques (Saliva, Buccal Swab, Blood, Others) Players and Region - Global Market Outlook to 2026

Nutrigenomics Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 5.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Nutrigenomics is defined as basically interaction of nutrition and genes in order to the treatment of disease. It is also known as nutritional genomics. Advantages of nutrigenomics testing allow them to make positive changes to their lifestyle, shifting the focus from disease management to disease prevention and health promotion and other benefits. Introduction and development of direct to consumer nutrigenomics kits and rising intake of specialized food and diet are some of the major drivers which are propelling the growth of the market.According to AMA, the market for Nutrigenomics is expected to register a CAGR of 5.2% during the forecast period to 2026. This growth is primarily driven by Rising Healthcare Expenditure, and Encouraging Government Support for Research and Development, Increasing Awareness of Health and Treatments and Increased Spending On Healthcare and a Demand for Holistic Treatments.

Globally, a noticeable market trend is evident Technology Advancement in Nutrigenomics. The Biotechnology sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Cura Integrative Medicine (Australia), NutraGene (United States), XCODE Life Science Pvt. Ltd. (India), Nutrigenomix (Canada), WellGen Inc. (United States), Genomix Nutrition Inc. (United States), Royal DSM (Netherlands), BASF SE (Germany), Danone S.A (France) and GeneSmart (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In April 2018, the Prenetics Limited (Hong Kong) Company has acquired DNAFit Ltd (United Kingdom) Company for more than USD 10 Million, which serves customers with pharmacogenomics, nutrigenomics, cancer, and reproductive health tests. Hence, this acquisition will help in strengthening the position of the company.

Market Drivers
  • Rising Healthcare Expenditure, and Encouraging Government Support for Research and Development
  • Increasing Awareness of Health and Treatments
  • Increased Spending On Healthcare and a Demand for Holistic Treatments

Market Trend
  • Technology Advancement in Nutrigenomics

Restraints
  • Issue related to High Cost Associated with the Treatment

Opportunities
Growing Demand from Emerging Economies such as China as well as India
Challenges
Lack of Physicians Qualified to Provide Nutrigenomics Treatments

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Nutrigenomics Study Sheds Light on
— The Nutrigenomics Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Nutrigenomics industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Nutrigenomics industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Reagents & kits
  • Services
By Application
  • Obesity
  • Diabetes
  • Anti-Aging
  • Chronic Diseases
By Techniques
  • Saliva
  • Buccal Swab
  • Blood
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Healthcare Expenditure, and Encouraging Government Support for Research and Development
      • 3.2.2. Increasing Awareness of Health and Treatments
      • 3.2.3. Increased Spending On Healthcare and a Demand for Holistic Treatments
    • 3.3. Market Challenges
      • 3.3.1. Lack of Physicians Qualified to Provide Nutrigenomics Treatments
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in Nutrigenomics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Nutrigenomics, by Type, Application, Techniques and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Nutrigenomics (Value)
      • 5.2.1. Global Nutrigenomics by: Type (Value)
        • 5.2.1.1. Reagents & kits
        • 5.2.1.2. Services
      • 5.2.2. Global Nutrigenomics by: Application (Value)
        • 5.2.2.1. Obesity
        • 5.2.2.2. Diabetes
        • 5.2.2.3. Anti-Aging
        • 5.2.2.4. Chronic Diseases
      • 5.2.3. Global Nutrigenomics by: Techniques (Value)
        • 5.2.3.1. Saliva
        • 5.2.3.2. Buccal Swab
        • 5.2.3.3. Blood
        • 5.2.3.4. Others
      • 5.2.4. Global Nutrigenomics Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Nutrigenomics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cura Integrative Medicine (Australia)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. NutraGene (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. XCODE Life Science Pvt. Ltd. (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Nutrigenomix (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. WellGen Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Genomix Nutrition Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Royal DSM (Netherlands)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BASF SE (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Danone S.A (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GeneSmart (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Nutrigenomics Sale, by Type, Application, Techniques and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Nutrigenomics (Value)
      • 7.2.1. Global Nutrigenomics by: Type (Value)
        • 7.2.1.1. Reagents & kits
        • 7.2.1.2. Services
      • 7.2.2. Global Nutrigenomics by: Application (Value)
        • 7.2.2.1. Obesity
        • 7.2.2.2. Diabetes
        • 7.2.2.3. Anti-Aging
        • 7.2.2.4. Chronic Diseases
      • 7.2.3. Global Nutrigenomics by: Techniques (Value)
        • 7.2.3.1. Saliva
        • 7.2.3.2. Buccal Swab
        • 7.2.3.3. Blood
        • 7.2.3.4. Others
      • 7.2.4. Global Nutrigenomics Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nutrigenomics: by Type(USD Million)
  • Table 2. Nutrigenomics Reagents & kits , by Region USD Million (2015-2020)
  • Table 3. Nutrigenomics Services , by Region USD Million (2015-2020)
  • Table 4. Nutrigenomics: by Application(USD Million)
  • Table 5. Nutrigenomics Obesity , by Region USD Million (2015-2020)
  • Table 6. Nutrigenomics Diabetes , by Region USD Million (2015-2020)
  • Table 7. Nutrigenomics Anti-Aging , by Region USD Million (2015-2020)
  • Table 8. Nutrigenomics Chronic Diseases , by Region USD Million (2015-2020)
  • Table 9. Nutrigenomics: by Techniques(USD Million)
  • Table 10. Nutrigenomics Saliva , by Region USD Million (2015-2020)
  • Table 11. Nutrigenomics Buccal Swab , by Region USD Million (2015-2020)
  • Table 12. Nutrigenomics Blood , by Region USD Million (2015-2020)
  • Table 13. Nutrigenomics Others , by Region USD Million (2015-2020)
  • Table 14. South America Nutrigenomics, by Country USD Million (2015-2020)
  • Table 15. South America Nutrigenomics, by Type USD Million (2015-2020)
  • Table 16. South America Nutrigenomics, by Application USD Million (2015-2020)
  • Table 17. South America Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 18. Brazil Nutrigenomics, by Type USD Million (2015-2020)
  • Table 19. Brazil Nutrigenomics, by Application USD Million (2015-2020)
  • Table 20. Brazil Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 21. Argentina Nutrigenomics, by Type USD Million (2015-2020)
  • Table 22. Argentina Nutrigenomics, by Application USD Million (2015-2020)
  • Table 23. Argentina Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 24. Rest of South America Nutrigenomics, by Type USD Million (2015-2020)
  • Table 25. Rest of South America Nutrigenomics, by Application USD Million (2015-2020)
  • Table 26. Rest of South America Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 27. Asia Pacific Nutrigenomics, by Country USD Million (2015-2020)
  • Table 28. Asia Pacific Nutrigenomics, by Type USD Million (2015-2020)
  • Table 29. Asia Pacific Nutrigenomics, by Application USD Million (2015-2020)
  • Table 30. Asia Pacific Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 31. China Nutrigenomics, by Type USD Million (2015-2020)
  • Table 32. China Nutrigenomics, by Application USD Million (2015-2020)
  • Table 33. China Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 34. Japan Nutrigenomics, by Type USD Million (2015-2020)
  • Table 35. Japan Nutrigenomics, by Application USD Million (2015-2020)
  • Table 36. Japan Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 37. India Nutrigenomics, by Type USD Million (2015-2020)
  • Table 38. India Nutrigenomics, by Application USD Million (2015-2020)
  • Table 39. India Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 40. South Korea Nutrigenomics, by Type USD Million (2015-2020)
  • Table 41. South Korea Nutrigenomics, by Application USD Million (2015-2020)
  • Table 42. South Korea Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 43. Taiwan Nutrigenomics, by Type USD Million (2015-2020)
  • Table 44. Taiwan Nutrigenomics, by Application USD Million (2015-2020)
  • Table 45. Taiwan Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 46. Australia Nutrigenomics, by Type USD Million (2015-2020)
  • Table 47. Australia Nutrigenomics, by Application USD Million (2015-2020)
  • Table 48. Australia Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Nutrigenomics, by Type USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Nutrigenomics, by Application USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 52. Europe Nutrigenomics, by Country USD Million (2015-2020)
  • Table 53. Europe Nutrigenomics, by Type USD Million (2015-2020)
  • Table 54. Europe Nutrigenomics, by Application USD Million (2015-2020)
  • Table 55. Europe Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 56. Germany Nutrigenomics, by Type USD Million (2015-2020)
  • Table 57. Germany Nutrigenomics, by Application USD Million (2015-2020)
  • Table 58. Germany Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 59. France Nutrigenomics, by Type USD Million (2015-2020)
  • Table 60. France Nutrigenomics, by Application USD Million (2015-2020)
  • Table 61. France Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 62. Italy Nutrigenomics, by Type USD Million (2015-2020)
  • Table 63. Italy Nutrigenomics, by Application USD Million (2015-2020)
  • Table 64. Italy Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 65. United Kingdom Nutrigenomics, by Type USD Million (2015-2020)
  • Table 66. United Kingdom Nutrigenomics, by Application USD Million (2015-2020)
  • Table 67. United Kingdom Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 68. Netherlands Nutrigenomics, by Type USD Million (2015-2020)
  • Table 69. Netherlands Nutrigenomics, by Application USD Million (2015-2020)
  • Table 70. Netherlands Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 71. Rest of Europe Nutrigenomics, by Type USD Million (2015-2020)
  • Table 72. Rest of Europe Nutrigenomics, by Application USD Million (2015-2020)
  • Table 73. Rest of Europe Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 74. MEA Nutrigenomics, by Country USD Million (2015-2020)
  • Table 75. MEA Nutrigenomics, by Type USD Million (2015-2020)
  • Table 76. MEA Nutrigenomics, by Application USD Million (2015-2020)
  • Table 77. MEA Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 78. Middle East Nutrigenomics, by Type USD Million (2015-2020)
  • Table 79. Middle East Nutrigenomics, by Application USD Million (2015-2020)
  • Table 80. Middle East Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 81. Africa Nutrigenomics, by Type USD Million (2015-2020)
  • Table 82. Africa Nutrigenomics, by Application USD Million (2015-2020)
  • Table 83. Africa Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 84. North America Nutrigenomics, by Country USD Million (2015-2020)
  • Table 85. North America Nutrigenomics, by Type USD Million (2015-2020)
  • Table 86. North America Nutrigenomics, by Application USD Million (2015-2020)
  • Table 87. North America Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 88. United States Nutrigenomics, by Type USD Million (2015-2020)
  • Table 89. United States Nutrigenomics, by Application USD Million (2015-2020)
  • Table 90. United States Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 91. Canada Nutrigenomics, by Type USD Million (2015-2020)
  • Table 92. Canada Nutrigenomics, by Application USD Million (2015-2020)
  • Table 93. Canada Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 94. Mexico Nutrigenomics, by Type USD Million (2015-2020)
  • Table 95. Mexico Nutrigenomics, by Application USD Million (2015-2020)
  • Table 96. Mexico Nutrigenomics, by Techniques USD Million (2015-2020)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Nutrigenomics: by Type(USD Million)
  • Table 108. Nutrigenomics Reagents & kits , by Region USD Million (2021-2026)
  • Table 109. Nutrigenomics Services , by Region USD Million (2021-2026)
  • Table 110. Nutrigenomics: by Application(USD Million)
  • Table 111. Nutrigenomics Obesity , by Region USD Million (2021-2026)
  • Table 112. Nutrigenomics Diabetes , by Region USD Million (2021-2026)
  • Table 113. Nutrigenomics Anti-Aging , by Region USD Million (2021-2026)
  • Table 114. Nutrigenomics Chronic Diseases , by Region USD Million (2021-2026)
  • Table 115. Nutrigenomics: by Techniques(USD Million)
  • Table 116. Nutrigenomics Saliva , by Region USD Million (2021-2026)
  • Table 117. Nutrigenomics Buccal Swab , by Region USD Million (2021-2026)
  • Table 118. Nutrigenomics Blood , by Region USD Million (2021-2026)
  • Table 119. Nutrigenomics Others , by Region USD Million (2021-2026)
  • Table 120. South America Nutrigenomics, by Country USD Million (2021-2026)
  • Table 121. South America Nutrigenomics, by Type USD Million (2021-2026)
  • Table 122. South America Nutrigenomics, by Application USD Million (2021-2026)
  • Table 123. South America Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 124. Brazil Nutrigenomics, by Type USD Million (2021-2026)
  • Table 125. Brazil Nutrigenomics, by Application USD Million (2021-2026)
  • Table 126. Brazil Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 127. Argentina Nutrigenomics, by Type USD Million (2021-2026)
  • Table 128. Argentina Nutrigenomics, by Application USD Million (2021-2026)
  • Table 129. Argentina Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 130. Rest of South America Nutrigenomics, by Type USD Million (2021-2026)
  • Table 131. Rest of South America Nutrigenomics, by Application USD Million (2021-2026)
  • Table 132. Rest of South America Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 133. Asia Pacific Nutrigenomics, by Country USD Million (2021-2026)
  • Table 134. Asia Pacific Nutrigenomics, by Type USD Million (2021-2026)
  • Table 135. Asia Pacific Nutrigenomics, by Application USD Million (2021-2026)
  • Table 136. Asia Pacific Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 137. China Nutrigenomics, by Type USD Million (2021-2026)
  • Table 138. China Nutrigenomics, by Application USD Million (2021-2026)
  • Table 139. China Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 140. Japan Nutrigenomics, by Type USD Million (2021-2026)
  • Table 141. Japan Nutrigenomics, by Application USD Million (2021-2026)
  • Table 142. Japan Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 143. India Nutrigenomics, by Type USD Million (2021-2026)
  • Table 144. India Nutrigenomics, by Application USD Million (2021-2026)
  • Table 145. India Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 146. South Korea Nutrigenomics, by Type USD Million (2021-2026)
  • Table 147. South Korea Nutrigenomics, by Application USD Million (2021-2026)
  • Table 148. South Korea Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 149. Taiwan Nutrigenomics, by Type USD Million (2021-2026)
  • Table 150. Taiwan Nutrigenomics, by Application USD Million (2021-2026)
  • Table 151. Taiwan Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 152. Australia Nutrigenomics, by Type USD Million (2021-2026)
  • Table 153. Australia Nutrigenomics, by Application USD Million (2021-2026)
  • Table 154. Australia Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 155. Rest of Asia-Pacific Nutrigenomics, by Type USD Million (2021-2026)
  • Table 156. Rest of Asia-Pacific Nutrigenomics, by Application USD Million (2021-2026)
  • Table 157. Rest of Asia-Pacific Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 158. Europe Nutrigenomics, by Country USD Million (2021-2026)
  • Table 159. Europe Nutrigenomics, by Type USD Million (2021-2026)
  • Table 160. Europe Nutrigenomics, by Application USD Million (2021-2026)
  • Table 161. Europe Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 162. Germany Nutrigenomics, by Type USD Million (2021-2026)
  • Table 163. Germany Nutrigenomics, by Application USD Million (2021-2026)
  • Table 164. Germany Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 165. France Nutrigenomics, by Type USD Million (2021-2026)
  • Table 166. France Nutrigenomics, by Application USD Million (2021-2026)
  • Table 167. France Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 168. Italy Nutrigenomics, by Type USD Million (2021-2026)
  • Table 169. Italy Nutrigenomics, by Application USD Million (2021-2026)
  • Table 170. Italy Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 171. United Kingdom Nutrigenomics, by Type USD Million (2021-2026)
  • Table 172. United Kingdom Nutrigenomics, by Application USD Million (2021-2026)
  • Table 173. United Kingdom Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 174. Netherlands Nutrigenomics, by Type USD Million (2021-2026)
  • Table 175. Netherlands Nutrigenomics, by Application USD Million (2021-2026)
  • Table 176. Netherlands Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 177. Rest of Europe Nutrigenomics, by Type USD Million (2021-2026)
  • Table 178. Rest of Europe Nutrigenomics, by Application USD Million (2021-2026)
  • Table 179. Rest of Europe Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 180. MEA Nutrigenomics, by Country USD Million (2021-2026)
  • Table 181. MEA Nutrigenomics, by Type USD Million (2021-2026)
  • Table 182. MEA Nutrigenomics, by Application USD Million (2021-2026)
  • Table 183. MEA Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 184. Middle East Nutrigenomics, by Type USD Million (2021-2026)
  • Table 185. Middle East Nutrigenomics, by Application USD Million (2021-2026)
  • Table 186. Middle East Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 187. Africa Nutrigenomics, by Type USD Million (2021-2026)
  • Table 188. Africa Nutrigenomics, by Application USD Million (2021-2026)
  • Table 189. Africa Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 190. North America Nutrigenomics, by Country USD Million (2021-2026)
  • Table 191. North America Nutrigenomics, by Type USD Million (2021-2026)
  • Table 192. North America Nutrigenomics, by Application USD Million (2021-2026)
  • Table 193. North America Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 194. United States Nutrigenomics, by Type USD Million (2021-2026)
  • Table 195. United States Nutrigenomics, by Application USD Million (2021-2026)
  • Table 196. United States Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 197. Canada Nutrigenomics, by Type USD Million (2021-2026)
  • Table 198. Canada Nutrigenomics, by Application USD Million (2021-2026)
  • Table 199. Canada Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 200. Mexico Nutrigenomics, by Type USD Million (2021-2026)
  • Table 201. Mexico Nutrigenomics, by Application USD Million (2021-2026)
  • Table 202. Mexico Nutrigenomics, by Techniques USD Million (2021-2026)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nutrigenomics: by Type USD Million (2015-2020)
  • Figure 5. Global Nutrigenomics: by Application USD Million (2015-2020)
  • Figure 6. Global Nutrigenomics: by Techniques USD Million (2015-2020)
  • Figure 7. South America Nutrigenomics Share (%), by Country
  • Figure 8. Asia Pacific Nutrigenomics Share (%), by Country
  • Figure 9. Europe Nutrigenomics Share (%), by Country
  • Figure 10. MEA Nutrigenomics Share (%), by Country
  • Figure 11. North America Nutrigenomics Share (%), by Country
  • Figure 12. Global Nutrigenomics share by Players 2020 (%)
  • Figure 13. Global Nutrigenomics share by Players (Top 3) 2020(%)
  • Figure 14. Global Nutrigenomics share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Cura Integrative Medicine (Australia) Revenue, Net Income and Gross profit
  • Figure 17. Cura Integrative Medicine (Australia) Revenue: by Geography 2020
  • Figure 18. NutraGene (United States) Revenue, Net Income and Gross profit
  • Figure 19. NutraGene (United States) Revenue: by Geography 2020
  • Figure 20. XCODE Life Science Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 21. XCODE Life Science Pvt. Ltd. (India) Revenue: by Geography 2020
  • Figure 22. Nutrigenomix (Canada) Revenue, Net Income and Gross profit
  • Figure 23. Nutrigenomix (Canada) Revenue: by Geography 2020
  • Figure 24. WellGen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. WellGen Inc. (United States) Revenue: by Geography 2020
  • Figure 26. Genomix Nutrition Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Genomix Nutrition Inc. (United States) Revenue: by Geography 2020
  • Figure 28. Royal DSM (Netherlands) Revenue, Net Income and Gross profit
  • Figure 29. Royal DSM (Netherlands) Revenue: by Geography 2020
  • Figure 30. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 31. BASF SE (Germany) Revenue: by Geography 2020
  • Figure 32. Danone S.A (France) Revenue, Net Income and Gross profit
  • Figure 33. Danone S.A (France) Revenue: by Geography 2020
  • Figure 34. GeneSmart (United States) Revenue, Net Income and Gross profit
  • Figure 35. GeneSmart (United States) Revenue: by Geography 2020
  • Figure 36. Global Nutrigenomics: by Type USD Million (2021-2026)
  • Figure 37. Global Nutrigenomics: by Application USD Million (2021-2026)
  • Figure 38. Global Nutrigenomics: by Techniques USD Million (2021-2026)
  • Figure 39. South America Nutrigenomics Share (%), by Country
  • Figure 40. Asia Pacific Nutrigenomics Share (%), by Country
  • Figure 41. Europe Nutrigenomics Share (%), by Country
  • Figure 42. MEA Nutrigenomics Share (%), by Country
  • Figure 43. North America Nutrigenomics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Cura Integrative Medicine (Australia)
  • NutraGene (United States)
  • XCODE Life Science Pvt. Ltd. (India)
  • Nutrigenomix (Canada)
  • WellGen Inc. (United States)
  • Genomix Nutrition Inc. (United States)
  • Royal DSM (Netherlands)
  • BASF SE (Germany)
  • Danone S.A (France)
  • GeneSmart (United States)
Additional players considered in the study are as follows:
Unilever (United Kingdom) , Genova Diagnostics (United States) , NutriGenomix, Inc. (Canada) , Metagenics, Inc. (United States) , WellGen, Inc. (United States)
Select User Access Type

Key Highlights of Report


Sep 2021 220 Pages 68 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Nutrigenomics Market Quantitative research analysis
Global Nutrigenomics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Nutrigenomics market is expected to see a CAGR of 5.2% during projected year 2020 to 2026.
Top performing companies in the Global Nutrigenomics market are Cura Integrative Medicine (Australia), NutraGene (United States), XCODE Life Science Pvt. Ltd. (India), Nutrigenomix (Canada), WellGen Inc. (United States), Genomix Nutrition Inc. (United States), Royal DSM (Netherlands), BASF SE (Germany), Danone S.A (France) and GeneSmart (United States), to name a few.
North America is dominating the Nutrigenomics Market.

Know More About Global Nutrigenomics Market Report?

Have a Query? Click Here

Other Related Reports

Genetically Modified Food Comprehensive Study by Type (Herbicide Tolerance (HR), Insect Resistance (IR), Stacked Traits (ST)), Application (Crops, Vegetables, Fruits, Animal Products), Crop (Corn, Co...
$ 3350
Plasmid DNA Manufacturing Comprehensive Study by Type (HQ Plasmid DNA, GMP Plasmid DNA, Non-GMP Plasmid DNA), Application (Cancer, Inherited Disorders, Viral Infections, DNA vaccines, DNA-based gene ...
$ 3750
Clinical Oncology Next Generation Sequencing (NGS) Comprehensive Study by Type (NGS Pre-Sequencing, Sequencing, NGS Data Analysis, Primary, Secondary & Tertiary Data Analysis), Application (Academic ...
$ 3750
Protein Crystallization Comprehensive Study by Application (Silico Drug Design, Binding Site Determination, Membrane Protein Structure Analysis, Others), Industry Verticals (Biotechnology, Pharmaceut...
$ 3750
Bioprocess Analyzers Comprehensive Study by Type (Substrate Analysis, Metabolite Analysis, Concentration Detection), Application (Antibiotics, Recombinant Proteins, Biosimilars, Others), Technology T...
$ 3650
Viral Vector and Plasmid DNA Manufacturing Comprehensive Study by Type (Viral Vector {Retroviral, Adenoviral, Lentiviral, Adenoassociated and Other}, Plasmid DNA, Non-Viral Vector), Application (Canc...
$ 3650